Your browser doesn't support javascript.
loading
A high-throughput drug screen reveals means to differentiate triple-negative breast cancer.
Vulin, Milica; Jehanno, Charly; Sethi, Atul; Correia, Ana Luísa; Obradovic, Milan M S; Couto, Joana Pinto; Coissieux, Marie-May; Diepenbruck, Maren; Preca, Bogdan-Tiberius; Volkmann, Katrin; der Maur, Priska Auf; Schmidt, Alexander; Münst, Simone; Sauteur, Loïc; Kloc, Michal; Palafox, Marta; Britschgi, Adrian; Unterreiner, Vincent; Galuba, Olaf; Claerr, Isabelle; Lopez-Romero, Sandra; Galli, Giorgio G; Baeschlin, Daniel; Okamoto, Ryoko; Soysal, Savas D; Mechera, Robert; Weber, Walter P; Radimerski, Thomas; Bentires-Alj, Mohamed.
Afiliación
  • Vulin M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Jehanno C; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Sethi A; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Correia AL; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Obradovic MMS; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Couto JP; Swiss Institute of Bioinformatics, Basel, Switzerland.
  • Coissieux MM; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Diepenbruck M; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Preca BT; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Volkmann K; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • der Maur PA; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Schmidt A; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Münst S; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Sauteur L; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Kloc M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Palafox M; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Britschgi A; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Unterreiner V; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Galuba O; Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland.
  • Claerr I; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Lopez-Romero S; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Galli GG; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Baeschlin D; Swiss Institute of Bioinformatics, Basel, Switzerland.
  • Okamoto R; Department of Biomedicine, Department of Surgery, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Soysal SD; Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland.
  • Mechera R; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Weber WP; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Radimerski T; Novartis Institutes for Biomedical Research, Basel, Switzerland.
  • Bentires-Alj M; Novartis Institutes for Biomedical Research, Basel, Switzerland.
Oncogene ; 41(39): 4459-4473, 2022 09.
Article en En | MEDLINE | ID: mdl-36008466
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Suiza Pais de publicación: Reino Unido